Skip to main content

A PheWAS approach in studying HLA-DRB1*1501.

Publication ,  Journal Article
Hebbring, SJ; Schrodi, SJ; Ye, Z; Zhou, Z; Page, D; Brilliant, MH
Published in: Genes Immun
April 2013

HLA-DRB1 codes for a major histocompatibility complex class II cell surface receptor. Genetic variants in and around this gene have been linked to numerous autoimmune diseases. Most notably, an association between HLA-DRB1*1501 haplotype and multiple sclerosis (MS) has been defined. Utilizing electronic health records and 4235 individuals within Marshfield Clinic's Personalized Medicine Research Project, a reverse genetic screen coined phenome-wide association study (PheWAS) tested association of rs3135388 genotype (tagging HLA-DRB1*1501) with 4841 phenotypes. As expected, HLA-DRB1*1501 was associated with MS (International Classification of Disease version 9-CM (ICD9) 340, P=0.023), whereas the strongest association was with alcohol-induced cirrhosis of the liver (ICD9 571.2, P=0.00011). HLA-DRB1*1501 also demonstrated association with erythematous conditions (ICD9 695, P=0.0054) and benign neoplasms of the respiratory and intrathoracic organs (ICD9 212, P=0.042), replicating previous findings. This study not only builds on the feasibility/utility of the PheWAS approach, represents the first external validation of a PheWAS, but may also demonstrate the complex etiologies associated with the HLA-DRB1*1501 loci.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Genes Immun

DOI

EISSN

1476-5470

Publication Date

April 2013

Volume

14

Issue

3

Start / End Page

187 / 191

Location

England

Related Subject Headings

  • Reproducibility of Results
  • Polymorphism, Single Nucleotide
  • Phenotype
  • Multiple Sclerosis
  • Middle Aged
  • Liver Diseases, Alcoholic
  • International Classification of Diseases
  • Immunology
  • Humans
  • Haplotypes
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Hebbring, S. J., Schrodi, S. J., Ye, Z., Zhou, Z., Page, D., & Brilliant, M. H. (2013). A PheWAS approach in studying HLA-DRB1*1501. Genes Immun, 14(3), 187–191. https://doi.org/10.1038/gene.2013.2
Hebbring, S. J., S. J. Schrodi, Z. Ye, Z. Zhou, D. Page, and M. H. Brilliant. “A PheWAS approach in studying HLA-DRB1*1501.Genes Immun 14, no. 3 (April 2013): 187–91. https://doi.org/10.1038/gene.2013.2.
Hebbring SJ, Schrodi SJ, Ye Z, Zhou Z, Page D, Brilliant MH. A PheWAS approach in studying HLA-DRB1*1501. Genes Immun. 2013 Apr;14(3):187–91.
Hebbring, S. J., et al. “A PheWAS approach in studying HLA-DRB1*1501.Genes Immun, vol. 14, no. 3, Apr. 2013, pp. 187–91. Pubmed, doi:10.1038/gene.2013.2.
Hebbring SJ, Schrodi SJ, Ye Z, Zhou Z, Page D, Brilliant MH. A PheWAS approach in studying HLA-DRB1*1501. Genes Immun. 2013 Apr;14(3):187–191.

Published In

Genes Immun

DOI

EISSN

1476-5470

Publication Date

April 2013

Volume

14

Issue

3

Start / End Page

187 / 191

Location

England

Related Subject Headings

  • Reproducibility of Results
  • Polymorphism, Single Nucleotide
  • Phenotype
  • Multiple Sclerosis
  • Middle Aged
  • Liver Diseases, Alcoholic
  • International Classification of Diseases
  • Immunology
  • Humans
  • Haplotypes